Beta-2-microglobulin: A valuable parameter of stage, prognosis and response to treatment in myelomatosis
- 24 April 2009
- journal article
- Published by Wiley in Scandinavian Journal of Haematology
- Vol. 35 (1) , 22-25
- https://doi.org/10.1111/j.1600-0609.1985.tb00794.x
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Prognostic significance of pretreatment serum β2-microglobulin levels in multiple myelomaEuropean Journal of Cancer and Clinical Oncology, 1983
- Serum beta-2-microglobulin in multiple myeloma: Relation to presenting features and clinical statusEuropean Journal of Cancer and Clinical Oncology, 1982
- Turnover in humans of β2‐microglobulin: the constant chain of HLA‐antigensEuropean Journal of Clinical Investigation, 1980
- Distribution of ‘Free’ and HLA‐associated Human β2‐Microglobulin in Some Plasma Membranes and Biological FluidsScandinavian Journal of Immunology, 1980
- Radioimmunologische Bestimmung von β2-Mikroglobulin bei monoklonalen GammopathienDeutsche Medizinische Wochenschrift (1946), 1978
- Lymphocyte Associated beta2-Microglobulin Studied by Crossed RadioimmunoelectrophoresisScandinavian Journal of Immunology, 1978
- β2-MICROGLOBULIN, A TUMOUR MARKER OF LYMPHOPROLIFERATIVE DISORDERSThe Lancet, 1978
- β2-Microglobulin levels in cancerous and other disease statesClinica Chimica Acta; International Journal of Clinical Chemistry, 1976
- Production of β2‐Microglobulin by Normal and Malignant Human Cell Lines and Peripheral LymphocytesImmunological Reviews, 1974
- Physical-chemical properties of β2-microglobulinImmunochemistry, 1974